Monitoring the Prevalence of Antimicrobial Resistance in Companion Animals: Results from Clinical Isolates in an Italian University Veterinary Hospital
Table 4
Univariable logistic regression results from a study associating risk factors to antimicrobial resistance (AMR) or multidrug resistance (MDR) in 940 analyzed isolates collected from dogs and cats referred to a Veterinary University Hospital between November 2020 and September 2022.
Variables
AMR
MDR
p Value
OR (95% CI)
p Value
OR (95(%) CI)
Species (dog)
1.62(1.13–2.32)
0.66
1.07 (0.78–1.48)
Age (years)
0.52
0.99 (0.95–1.03)
0.36
0.99 (0.96–1.02)
Previous hospitalization/surgery in the past 30 days (yes)
3.14 (1.83–5.39)
2.76 (1.97–3.87)
Hospitalization at the time of the sampling (yes)
0.80
1.04 (0.75–1.45)
1.33 (1.02–1.73)
Hospitalization in intensive care unit (yes)
0.85
0.96 (0.65–1.42)
1.46 (1.06–2.00)
Surgery at the time of the sampling (yes)
0.70
0.93 (0.64–1.35)
0.67
0.94 (0.69–1.27)
Days of hospitalization at the time of the sampling (number of days)
0.10
1.06 (0.98–1.14)
1.08 (1.03–1.14)
Invasive device use in the previous 90 days (yes)
3.23 (2.07–5.05)
2.62 (1.96–3.50)
Antimicrobial use in the past 90 days (yes)
4.52 (3.07–6.65)
2.892 (2.29–3.66)
Current antimicrobial use (yes)
0.18
1.23 (0.91–1.67)
1.63 (1.28–2.07)
Note: Included in the multivariable analysis. Results considered significant (, marked with ) were included in the multivariable analysis model. Odds ratios (OR) are reported with 95% confidence interval (CI).
